181 related articles for article (PubMed ID: 36923722)
1. Rate of castration-induced prostate stroma regression is reduced in a mouse model of benign prostatic hyperplasia.
Zhang R; Singh S; Pan C; Xu B; Kindblom J; Eng KH; Krolewski JJ; Nastiuk KL
Am J Clin Exp Urol; 2023; 11(1):12-26. PubMed ID: 36923722
[TBL] [Abstract][Full Text] [Related]
2. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy.
Dos Santos L; Carbone F; Pacreau E; Diarra S; Luka M; Pigat N; Baures M; Navarro E; Anract J; Barry Delongchamps N; Cagnard N; Bost F; Nemazanyy I; Petitjean O; Hamaï A; Ménager M; Palea S; Guidotti JE; Goffin V
Am J Pathol; 2024 Jan; 194(1):30-51. PubMed ID: 37827216
[TBL] [Abstract][Full Text] [Related]
3. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
[TBL] [Abstract][Full Text] [Related]
4. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.
Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Törnell J; Wennbo H
Endocrinology; 2003 Jun; 144(6):2269-78. PubMed ID: 12746285
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.
Dillner K; Kindblom J; Flores-Morales A; Shao R; Törnell J; Norstedt G; Wennbo H
Endocrinology; 2003 Nov; 144(11):4955-66. PubMed ID: 12960074
[TBL] [Abstract][Full Text] [Related]
6. Combined
Pigat N; Reyes-Gomez E; Boutillon F; Palea S; Barry Delongchamps N; Koch E; Goffin V
Front Pharmacol; 2019; 10():311. PubMed ID: 30984003
[TBL] [Abstract][Full Text] [Related]
7. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
8. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review.
Vickman RE; Franco OE; Moline DC; Vander Griend DJ; Thumbikat P; Hayward SW
Asian J Urol; 2020 Jul; 7(3):191-202. PubMed ID: 32742923
[TBL] [Abstract][Full Text] [Related]
9. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
10. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor roles in the development of benign prostate hyperplasia.
Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
Logan YT; Belgeri MT
Am J Geriatr Pharmacother; 2005 Jun; 3(2):103-14. PubMed ID: 16129387
[TBL] [Abstract][Full Text] [Related]
14. Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure.
Kajiwara S; Ishii K; Sasaki T; Kato M; Nishikawa K; Kanda H; Arima K; Watanabe M; Sugimura Y
Lab Invest; 2020 May; 100(5):670-681. PubMed ID: 31857695
[TBL] [Abstract][Full Text] [Related]
15. Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia.
Wang X; Guo L; Liu G; Liu T
Diabetes Metab Syndr Obes; 2023; 16():3261-3273. PubMed ID: 37876983
[TBL] [Abstract][Full Text] [Related]
16. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
[TBL] [Abstract][Full Text] [Related]
18. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
[TBL] [Abstract][Full Text] [Related]
19. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and therapy of benign prostatic hyperplasia].
Sampson N; Madersbacher S; Berger P
Wien Klin Wochenschr; 2008; 120(13-14):390-401. PubMed ID: 18726663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
